MYC and colonic neoplasm: Therefore, having established that all the three ASO-like 10–23 variants can achieve potent and durable inhibition of constitutively expressed exogenous eGFP in HeLa cells, we further established their activities on endogenous c-MYC mRNA knockdown in colon cancer HCT116 cells (Fig. 5A).